Clinical Trials Browser

Interventional × Non-alcoholic Fatty Liver Disease × Gastrointestinal × Clear all

NCT04550481 2026-01-21

Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

Phase 2 Active not recruiting

45 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Non-alcoholic Fatty Liver Disease

NCT06366425 2025-07-10

HEPGEN

Phase NA Recruiting

260 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease

NCT03534141 2025-05-16

MHALT

Phase NA Terminated

175 enrolled 19 charts

GastrointestinalGenitourinary

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hypothermia, Liver Cirrhosis, Alcoholic, Renal Insufficiency, Chronic, Acute Kidney Injury, End Stage Liver Disease, Non-alcoholic Fatty Liver Disease

NCT06101758 2023-10-26

SARCOLIVER

Phase NA Unknown

125 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease